Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Bolstered Neuronal Antioxidant Response May Confer Resistance to Development of Dementia in Individuals with Alzheimer’s Neuropathology by Ameliorating Amyloid-beta-Induced Oxidative Stress

Evidence

J Neurosci. 2021 Jul 21;41(29):6187-6189. doi: 10.1523/JNEUROSCI.0531-21.2021.

NO ABSTRACT

PMID:38566352 | DOI:10.1523/JNEUROSCI.0531-21.2021

Document this CPD Copy URL Button

Google

Google Keep Add to Google Keep

LinkedIn Share Share on Linkedin Share on Linkedin

Estimated reading time: 1 minute(s)

Latest: Psychiatryai.com #RAISR4D

Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️

Real-Time Evidence Search [Psychiatry]

AI Research [Andisearch.com]

Bolstered Neuronal Antioxidant Response May Confer Resistance to Development of Dementia in Individuals with Alzheimer’s Neuropathology by Ameliorating Amyloid-beta-Induced Oxidative Stress

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

Bolstered Neuronal Antioxidant Response May Confer Resistance to Development of Dementia in Individuals with Alzheimer’s Neuropathology by Ameliorating Amyloid-beta-Induced Oxidative Stress

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

Bolstered Neuronal Antioxidant Response May Confer Resistance to Development of Dementia in Individuals with Alzheimer’s Neuropathology by Ameliorating Amyloid-beta-Induced Oxidative Stress

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.